Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

BASF Aktie 11450563 / DE000BASF111

28.10.2025 17:58:24

EQS-Adhoc: BASF SE: BASF to begin share buyback program in November 2025

EQS-Ad-hoc: BASF SE / Key word(s): Share Buyback
BASF SE: BASF to begin share buyback program in November 2025

28-Oct-2025 / 17:58 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


BASF to begin share buyback program in November 2025

  • Own shares with a volume of up to €1.5 billion to be repurchased from November 2025 until June 2026
  • Program is part of the €4 billion share buyback announced in September 2024 until the end of 2028
  • Repurchased shares to be cancelled, reducing the share capital accordingly

In view of cash proceeds already received and further proceeds expected, particularly from portfolio measures, the Board of Executive Directors of BASF SE has today, October 28, 2025, resolved on a share buyback program. The program, which has a volume of up to €1.5 billion, is scheduled to start in November 2025 and be concluded by the end of June 2026. It is part of the share buyback announced at the Capital Markets Day in September 2024, with a total volume of €4 billion until the end of 2028. BASF SE will cancel all repurchased shares and reduce the share capital accordingly.

The share buyback program is based on the authorization granted by the Annual Shareholders’ Meeting of BASF SE on April 29, 2022, authorizing the Board of Executive Directors to purchase up to 10 percent of the issued shares at the time of the resolution (10 percent of the company’s share capital) until April 28, 2027. The purchase shall be conducted making use of the safe-harbor exemption for buyback programs in accordance with Article 5 of the EU Market Abuse Regulation (MAR).

In the mid term, BASF is committed to keeping the overall distribution to shareholders at least on the level of the last years through a combination of dividends and share buybacks. In this way, BASF aims to distribute at least €12 billion to shareholders from 2025 to 2028. Specifically, the company strives to pay a dividend of at least €2.25 per share or around €2 billion per year. The aggregate dividend payment of around €8 billion in the four-year period will be complemented by share buybacks in the amount of at least €4 billion. These share buybacks were originally scheduled to begin by 2027 at the latest. Part of them will now be brought forward.

Through the share buyback, available capital will be returned to shareholders, the company’s capital structure optimized and earnings per share increased. BASF will also reduce net debt to strengthen its balance sheet. The maturity profile of outstanding bonds will allow considerable deleveraging in 2026.

BASF continues to strive for a single A credit rating, which ensures unrestricted access to financial and capital markets. The company currently has a rating of A/F1/outlook stable from Fitch, of A3/P-2/outlook stable from Moody’s and A-/A-2/outlook stable from Standard & Poor’s.

 

Contact
Dr. Stefanie Wettberg
Investor Relations
+49 621-60-48002
stefanie.wettberg@basf.com

Jens Fey
Corporate Media Relations
+49 621-60-99123
jens.fey@basf.com



End of Inside Information

28-Oct-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: BASF SE
Carl-Bosch-Strasse 38
67056 Ludwigshafen
Germany
Phone: +49 (0)621 60-0
Fax: +49 (0)621 60-4 25 25
E-mail: info.service@basf.com
Internet: www.basf.com
ISIN: DE000BASF111, DE000A0JRFB0, Börse Dublin, Frankfurter Wertpapierbörse, DE000A0JRFA2, Börse Dublin, Frankfurter Wertpapierbörse, DE000A0JQF26, Börse Dublin, Frankfurter Wertpapierbörse, DE000A0EUB86, Frankfurter Wertpapierbörse, DE0008846718, Frankfurter Wertpapierbörse, DE000A0XFK16, Börse Luxemburg, Frankfurter Wertpapierbörse, XS0420401779, Börse Luxemburg, XS0412154378, Börse Luxemburg, Frankfurter Börse, DE000A0T4DU7,Börse Luxemburg, Frankfurter Börse, CH0039943292, Swiss Exchange (SWX), CH0039943383, Swiss Exchange (SWX), DE000A0TKBM, Börse Luxemburg, Frankfurter Börse, XS0414672070, Börse Luxemburg, ,
WKN: BASF11, WKN A0JRFB, Börse Dublin, Frankfurter Wertpapierbörse, , WKN A0JRFA, Börse Dublin, Frankfurter Wertpapierbörse, , WKN A0JQF2, Börse Dublin, Frankfurter Wertpapierbörse, , WKN A0EUB8, Frankfurter Wertpapierbörse, , WKN 884671, Frankfurter Wertpapierbörse, , WKN A0XFK1, Börse Luxemburg, Frankfurter Wertpapierbörse, , WKN A0XFHJ, Börse Luxemburg, , WKN A0T6EG, Börse Luxemburg, Frankfurter Wertpapierbörse, , WKN A0T4DU, Börse Luxemburg, Frankfurter Wertpapierbörse, , WKN 3994329, Swiss Exchange (SWX), , WKN 3994338, Swiss Exchange (SWX), , WKN A0TKBM, Börse Luxemburg, Frankfurter Wertpapierbörse, , WKN A0T65R, Börse Luxemburg,
Indices: DAX, EURO STOXX 50
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart; Regulated Unofficial Market in Tradegate Exchange; London, SIX
EQS News ID: 2220042

 
End of Announcement EQS News Service

2220042  28-Oct-2025 CET/CEST

Analysen zu BASF

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
10:52 BASF Neutral UBS AG
10:16 BASF Hold Warburg Research
08:43 BASF Hold Jefferies & Company Inc.
08:39 BASF Outperform Bernstein Research
08:32 BASF Underweight JP Morgan Chase & Co.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.

Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.

🎯 Themen im Interview mit Etienne Jornod (OM Pharma)

– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments

👉🏽 https://bxplus.ch/bx-musterportfolio/

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’883.91 19.26 B1LSOU
Short 13’136.54 13.87 B02SIU
Short 13’648.79 8.82 BE6SJU
SMI-Kurs: 12’339.73 29.10.2025 14:28:31
Long 11’841.51 19.87 SQFBLU
Long 11’538.54 13.49 BO0SVU
Long 11’008.02 8.64 BMQS4U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

BASF 62.25 -2.00% BASF